期刊文献+

HPLC-MS/MS法测定达卡巴嗪脂质体的血药浓度

Determination the concentration of dacarbazinelipidosome in plasma by HPLC-MS/MS
原文传递
导出
摘要 目的建立高效液相色谱-质谱联用法(HPLC-MS/MS)测定血浆中达卡巴嗪(DTIC)的浓度。方法以电喷雾离子源(ESI)正离子模式,甲硝唑(MTZ)为内标定量,达卡巴嗪检测离子对为m/z 183.2→m/z 166.1;甲硝唑检测离子对为m/z 172.1→m/z 128.1,乙腈沉淀蛋白处理,用Dikmatech Easy GuardⅡHolder Assem Lly保护柱,Dikmatech C18(2.1 mm×50 mm,3μm)分析柱分离样品,流动相:水(含10 mmol·L^(-1)乙酸铵,0.1%乙酸,用氨水调p H至6.0)-乙腈=94∶6(v∶v);流速:0.3 m L·min^(-1)。结果达卡巴嗪标准曲线方程为Y=0.106X+0.0969(R=0.998 8),在0.5~20μg·m L^(-1)线性关系良好,定量下限为0.5μg·m L^(-1),达卡巴嗪日内和日间精密度的相对标准偏差为1.30%~3.00%和2.19%~8.78%。结论本文建立的方法灵敏可靠,可用于测定血浆中达卡巴嗪脂质体的浓度。 Objective To establish a HPLC-MS/MS method to determinate dacarbazine concentrations in rat plasma. Methods The mass spectrometer was operated in positive electron spray lonization( ESI)model and used metronidazole as internal standard,m/z 183. 2 → m/z166. 1 and m/z 172. 1→m/z 128. 1 were used for the measurement of dacarbazine and metronidazole,respectively. The plasma was deproteinated by acetonitrile and separated by a Dikmatech Easy Guard Holder Assembly guard column and a Dikmatech C18( 2. 1 mm × 50 mm,3 μm) column with a mobile phase of water-acetonitrile solution( containing 10 mmol·L^(-1) ammonium acetate,p H6. 0,94 ∶ 6,v/v) at the flow rate of0. 3 m L·min^(-1). Results The linear range of dacarbazine was 0. 5-20μg·m L^(-1). The inter-day and intra-day precision relative standard deviation( RSD) of dacarbazine in plasma were 1. 30%-3. 00% and2. 19%-8. 78%. Conclusion The HPLC-MS/MS developed in this study is rapid,accurate and reliable,and was accurate for determination of dacarbazinelipidosome in rat plasma.
作者 王婷 童荣生 何林 王丽 邹静 师健友 WANG Ting;TONG Rong-sheng;HE Lin;WANG Li;ZOU Jing;SHI Jian-you(a Department of Pharmacy,The National Key Specialty Construction Project of Clinical Pharmacy;b.Department of Good Clinical Practice,Sichuan Academy of Medical Science& Sichuan Provincial People's Hospital,Chengdu 510072,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第17期2110-2112,2128,共4页 The Chinese Journal of Clinical Pharmacology
基金 四川省科技计划重点研发项目基金资助项目(2017SZ0134)
关键词 达卡巴嗪 脂质体 血药浓度 高效液相色谱-质谱 dacarbazine lipidosome plasma drug concentration HPLC - MS/MS
  • 相关文献

参考文献4

二级参考文献138

  • 1Giblin AV, Thomas JM. Inciden mortality and survival in cutaneous melanoma [ J ]. J Plast Reconstr Aesthet Surg, 2007,60( 1 ) :32 -40.
  • 2Coit D, Andtbacka R, Anker C J, et al. Melanoma [ J ]. J Natl Compr Canc Netw,2012,10:366 - 400.
  • 3Luce JK, Thurman WG, Isaacs BL, et al. Clinical trials with the antitumor agent 5-( 3, 3-dimethyl-l-triazeno) imidazole-4-carboxamide ( NSC-45388 ) [ J ]. Cancer Chemother Rep, 1970,54 (2) : 119 - 124.
  • 4Nathanson L, Wolter J, Horton J, et al. Characteristics of rognosis and response to an imidazole carboxamide in malignant elanoma [ J]. Clin Pharmacol Ther, 1971,12 (6) :955 -962.
  • 5Costanza ME, Nathanson L, Lenhard R, et al. Therapy of alignant melanoma with an imidazole carboxamide and bischlo-roethyl nitrosurea [ J ] Cancer, 1972,30 ( 6 ) : 1457 - 1461.
  • 6Lens MB, Eisen TG. Systemic chemotherapy in the treatment of malignant melanoma [ J ]. Expert Opin Pharmacother, 2003,4 ( 12 ) : 2205 - 2211.
  • 7Bleehen NM, Newlands ES, Lee SM,et al. Cancer research ampaign phase l/ trial of temozolomide in metastatic melanoma[ J]. J Clin Oncol, 1995,13 (4) :910 - 913.
  • 8Middleton MR, Grob JJ, Aaronson N, et al. Randomized phase m study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma [ J]. J Clin Oncol, 2000,18 ( 1 ) : 158 - 166.
  • 9Patel PM, Suciu S, Mortier L, et al. Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma : final results of a randomised phase III study ( EORTC 18032 ) [ J ]. Eur J Cancer, 2011,47 (10) : 1476 - 1483.
  • 10Calabresi E, Aapro M, Becquart D, et al: Multicenter phase trial of the single agent fotemustine in patients with advanced malignant melanoma [ J ]. Ann Oncol, 1991,2(5) :377 -378.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部